Shots: Gilead to acquire 49.9% stakes in Pionyr for $275M and get an exclusive option to acquire the remaining shares. Gilead may exercise its option upon completion of P-Ib studies for PY314 and PY159 or can exercise before the completion by paying $315M as option exercise fee Additionally, Pionyr will receive up to $1.15B as […]Read More
